2 years ago

Verastem Reports Second Quarter 2015 Financial and Corporate Results

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering along with creating drugs to always be able to treat cancer by the specific killing associated with cancer stem cells, nowadays reported economic results for read more...